Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Modular Flow Reactor Systems

Published: Friday, December 14, 2012
Last Updated: Friday, December 14, 2012
Bookmark and Share
New systems provide users with greater flexibility and broader synthesis capabilities.

Uniqsis has announced a new portfolio of modular flow systems, based around its Binary Pump Module (BPM) and FlowSyn™ flow reactor technology to provide users with greater flexibility and broader synthesis capabilities.

Uniqsis developed the original two-channel FlowSyn™ flow reactor system as a fully integrated ‘one box’ solution to make the emerging technology of continuous flow chemistry easily accessible to anyone with an interest in exploring and exploiting this exciting field of research.

This system, which handles simple homogeneous and heterogeneous reactions at the push of a button, represents an easy, hassle-free entry into continuous flow chemistry.

As users and applications have become more sophisticated, Uniqsis has developed more powerful and sophisticated FlowSyn™ systems, culminating in the FlowSyn™ Auto LF capable of executing multi-step, multi-reagent experiments completely automatically and unsupervised.

Since then, the number and variety of applications for continuous flow chemistry have continued to proliferate, requiring flow systems to be ever more flexible and more easily customized by users.

Uniqsis has responded to these requirements by developing the versatile Binary Pump Module (BPM), a stand-alone two-channel high-pressure reagent delivery system which can form the basis of a modular continuous flow system.

Users can add reactor modules of their choice to the BPM to create a modular system tailored to their specific application, with the BPM and its dedicated control software acting as the ‘hub’ for the system.

Uniqsis supplies a wide range of reactor modules and accessories for this purpose, including column, coil and chip reactors, heating and cooling modules, fraction collectors and data collection and reporting modules.

The latest module in the line-up is the Polar Bear Plus Flow reactor module which offers cooling technology in a compact and portable package.

Delivering temperatures from -40°C to +150°C without the need for cardice or liquid nitrogen, it can operate independently or be controlled via the BPM as a standalone flow chemistry system.

Capable of pumping up to 100 ml/min and operating at up to 200 bar, the BPM is available in a choice of three flow paths - PTFE, stainless steel and Hastelloy® - for optimum chemical compatibility.

To help users configure systems for their applications, Uniqsis has included a useful interactive system builder on its website www.uniqsis.com.

Paul Pergande, Managing Director of Uniqsis, comments: “It’s very exciting for us to be at the forefront of this dynamic new technology and to be able to develop our product offering in line with user requirements. When continuous flow chemistry first came into being, our goal was to make simple applications easily accessible to anyone who wanted to get to know the technology. The emphasis now is to ensure that users can exploit the technology to its full extent by giving them the tools and flexibility to develop new and exciting applications not previously attempted.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cambridge Reactor Design and Uniqsis Announce Joint Marketing Agreement
The companies have entered into a joint marketing agreement for the Gastropod gas introduction module and the Polar Bear low temperature reactor, for flow chemistry applications.
Monday, April 18, 2011
Flow Chemistry Company Moves Ahead
Significant developments have been reported by Uniqsis to develop a new concept in flow chemistry, leading to the launch of the FlowSyn™ Continuous Flow Reactor at the end of last year.
Monday, January 14, 2008
Microreaction System Nears Launch
Uniqsis Ltd. has announced major progress towards launching FlowSyn™ later in the year.
Wednesday, August 15, 2007
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!